SAN FRANCISCO, Feb. 16, 2016 /PRNewswire/ -- entrotech life sciences today announced that Dr. Morton Grosser has joined its Board of Directors. Dr. Grosser has helped shape Silicon Valley's successful entrepreneurial model for science and technology for 30 years. As a board member, Grosser will provide strategic direction for entrotech life sciences in developing its advanced life-saving technologies for critical care patients worldwide.
"entrotech life sciences invents new technologies that prevent infection and save lives. It's a privilege to join their ongoing effort to create solutions that will reduce preventable deaths on a global scale," said Dr. Grosser.
"We are elated to have Dr. Grosser on our team," said Jim McGuire, CEO of entrotech. "His remarkable track record in Silicon Valley will be an asset for us as we enter new scientific and technological territory. There is no question that Dr. Grosser will help accelerate our global success in reducing unnecessary patient deaths."
About Morton Grosser
Dr. Morton Grosser is the President of MG consulting and a Silicon Valley venture investor, consultant, and inventor. He has been a director of eight high-tech companies, a consultant to many premier venture capital partnerships, and a strategy advisor to Fortune 100 corporations ranging from Apple to Xerox. He has written eight books, more than 100 papers, and several articles for national publications. Dr. Grosser is a Fellow of two national institutes, currently serves on three boards and has fifteen patents issued or pending. He is a NASDAQ Financial Principal, holds a BS and MS from MIT, a PhD from Stanford University, and was an NIH Postdoctoral Fellow at UCLA Medical Center.
About entrotech life sciences
entrotech life sciences (ELS | San Francisco, CA) helps healthcare professionals committed to infection prevention rethink what is possible in protection of catheter and surgical patients. ELS is affiliated with Entrogroup (est. 1999), an organization focused on inventing advanced lifesaving combat military products, smart device protectors, and environmentally-friendly, and lightweight paint appliques. ChloraDerm™, the flagship ELS innovation, is the first and only transparent thin-film dressing with edge-to-edge Chlorhexidine, preventing bacterial regrowth with broad spectrum antimicrobial protection at the wound, primary dressing, or percutaneous medical device site for seven days. Visit: www.entrotechlifesciences.com/chloraderm
SOURCE entrotech life sciences